Ftse Mib
38.592,81
-0,48%
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
NASDAQ
18.196,22
0,70%
Bitcoin
86.089,10
-0,08%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aadi Bioscience Inc (AADI) Aadi Bioscience Inc (AADI) Notizie

Aadi Bioscience Inc

AADI
2,12
0,02 (0,95%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202523:55EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
06/3/202501:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202522:16EDGAR2Form 8-K - Current report
04/3/202522:05PRNUSAadi Bioscience Announces Closing of $100 Million PIPE..
04/3/202502:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202502:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202502:36EDGAR2Form 144 - Report of proposed sale of securities
03/3/202514:00PRNUSAadi Bioscience Announces Approval of All Proposals at..
24/2/202514:00PRNUSAadi Bioscience to Present at the TD Cowen 45th Annual..
19/2/202523:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/2/202522:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/2/202522:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/2/202514:00PRNUSAadi Bioscience Appoints David Dornan, PhD, as Chief..
14/2/202518:11EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
05/2/202522:49EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/2/202522:05PRNUSAadi Bioscience Filed Definitive Proxy Statement and..
31/1/202523:09EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
30/1/202501:01EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
24/1/202520:34EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
21/1/202522:54EDGAR2Form PREM14A - Preliminary proxy statements relating to..
30/12/202423:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202423:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
20/12/202412:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/12/202412:05EDGAR2Form 8-K - Current report
20/12/202400:30PRNUSAadi Bioscience Transforms with In-Licensing of Novel ADC..
06/11/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202414:05EDGAR2Form 8-K - Current report
06/11/202414:00PRNUSAadi Bioscience Announces Financial Results for the Third..
30/10/202421:05PRNUSAadi Bioscience to Report Third Quarter 2024 Results and..
04/10/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202401:01EDGAR2Form 144 - Report of proposed sale of securities
01/10/202423:35EDGAR2Form SC 13D/A - General Statement of Acquisition of..
30/9/202412:06EDGAR2Form 8-K - Current report
19/9/202422:13EDGAR2Form 8-K - Current report
05/9/202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202423:51EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
03/9/202416:40EDGAR2Form 144 - Report of proposed sale of securities
22/8/202422:15EDGAR2Form 8-K - Current report
21/8/202403:21EDGAR2Form 8-K - Current report
20/8/202423:00PRNUSAadi Bioscience Provides PRECISION1 Trial and Corporate..
07/8/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202414:02EDGAR2Form 8-K - Current report
07/8/202414:00PRNUSAadi Bioscience Announces Financial Results for the Second..
06/8/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202422:05PRNUSAadi Bioscience to Report Second Quarter 2024 Results and..
14/6/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 2,10 Min: 2,0416 Max: 2,2299
Chiusura: 2,10

La tua Cronologia

NASDAQ
AADI
Aadi Bioscience
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci